Julie Dyall

2.8k total citations · 2 hit papers
28 papers, 1.8k citations indexed

About

Julie Dyall is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Julie Dyall has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Julie Dyall's work include Viral Infections and Outbreaks Research (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Herpesvirus Infections and Treatments (7 papers). Julie Dyall is often cited by papers focused on Viral Infections and Outbreaks Research (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Herpesvirus Infections and Treatments (7 papers). Julie Dyall collaborates with scholars based in United States, Argentina and Canada. Julie Dyall's co-authors include Peter B. Jahrling, Lisa E. Hensley, Reed F. Johnson, Gene G. Olinger, Matthew B. Frieman, Jason Kindrachuk, Michael R. Holbrook, Brit J. Hart, Lisa M. Johansen and Thiagarajan Venkataraman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Julie Dyall

28 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

2014 475 citations Julie Dyall, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →
Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

2014 307 citations Jason Kindrachuk, Brit J. Hart et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Julie Dyall

Since Specialization

Citations

This map shows the geographic impact of Julie Dyall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Dyall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Dyall more than expected).

Fields of papers citing papers by Julie Dyall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Dyall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Dyall. The network helps show where Julie Dyall may publish in the future.

Co-authorship network of co-authors of Julie Dyall

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Dyall. A scholar is included among the top collaborators of Julie Dyall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Dyall. Julie Dyall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pyronaridine tetraphosphate efficacy against Ebola virus infection in guinea pig 2020 ·Antiviral Research ·Thomas R. Lane, (unknown), Jason E. Comer, Alexander N. Freiberg, Huanying Zhou, Julie Dyall, Michael R. Holbrook, Manu Anantpadma, Robert A. Davey, Peter B. Madrid, Sean Ekins	17
2	A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures 2020 ·Viruses ·Ryan P. Bennett, Courtney L. Finch, Elena Postnikova, (unknown), Yíngyún Caì, Shuǐqìng Yú, Janie Liang, Julie Dyall, Jason D. Salter, Harold C. Smith, Jens H. Kuhn	14
3	The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses 2020 ·Proceedings of the National Academy of Sciences ·Stuart Weston, Lauren Baracco, (unknown), Krystal Matthews, Marisa E. McGrath, James Logue, Janie Liang, Julie Dyall, Michael R. Holbrook, Lisa E. Hensley, Peter B. Jahrling, Wenbo Yu, Alexander D. MacKerell, Matthew B. Frieman	21
4	Repurposing Pyramax®, quinacrine and tilorone as treatments for Ebola virus disease 2020 ·Antiviral Research ·Thomas R. Lane, Julie Dyall, (unknown), (unknown), Daniel H. Foil, Huanying Zhou, Elena Postnikova, Janie Liang, Michael R. Holbrook, Peter B. Madrid, Sean Ekins	22
5	Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin 2019 ·PLoS neglected tropical diseases ·(unknown), Julie Dyall, Lisa Evans DeWald, Steven R. King, Derek Dube, Maureen Legendre, Elizabeth A. Nelson, (unknown), Robin Gross, (unknown), (unknown), Elena Postnikova, Janie Liang, (unknown), Jagathpala Shetty, Lisa E. Hensley, Peter B. Jahrling, Gene G. Olinger, Judith M. White, David M. Markovitz	34
6	In Vivo Activity of Amodiaquine against Ebola Virus Infection 2019 ·Scientific Reports ·Lisa Evans DeWald, Joshua C. Johnson, (unknown), (unknown), Elena Postnikova, Anna N. Honko, Krisztina Janosko, Louis Huzella, William E. Dowling, Ann E. Eakin, Blaire L. Osborn, Janet Gahagen, Liang Tang, Carol E. Green, Jon C. Mirsalis, Michael R. Holbrook, Peter B. Jahrling, Julie Dyall, Lisa E. Hensley	13
7	Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1 2018 ·PLoS Pathogens ·(unknown), Tao Ren, Hu Liu, (unknown), Kyung‐Ae Lee, Anna N. Honko, Huanying Zhou, Julie Dyall, Lisa E. Hensley, (unknown), James M. Cunningham	17
8	Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs 2018 ·PLoS ONE ·Elena Postnikova, Yu Cong, Lisa Evans DeWald, Julie Dyall, Shuǐqìng Yú, Brit J. Hart, Huanying Zhou, Robin Gross, James Logue, Yíngyún Caì, (unknown), Julia Michelotti, Anna N. Honko, Richard S. Bennett, Michael R. Holbrook, Gene G. Olinger, Lisa E. Hensley, Peter B. Jahrling	32
9	MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells 2018 ·PLoS ONE ·Yu Cong, Brit J. Hart, Robin Gross, Huanying Zhou, Matthew B. Frieman, Laura Bollinger, Jiro Wada, Lisa E. Hensley, Peter B. Jahrling, Julie Dyall, Michael R. Holbrook	80
10	Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies 2017 ·Drugs ·Julie Dyall, Robin Gross, Jason Kindrachuk, Reed F. Johnson, Gene G. Olinger, Lisa E. Hensley, Matthew B. Frieman, Peter B. Jahrling	141
11	[ ¹⁸ F]-Fluorodeoxyglucose Uptake in Lymphoid Tissue Serves as a Predictor of Disease Outcome in the Nonhuman Primate Model of Monkeypox Virus Infection 2017 ·Journal of Virology ·Julie Dyall, Reed F. Johnson, Svetlana I. Chefer, (unknown), David Thomasson, Jürgen Seidel, Dan R. Ragland, Russell Byrum, Catherine Jett, Jennifer Cann, Marisa St. Claire, Elaine M. Jagoda, Richard C. Reba, Dima A. Hammoud, Joseph E. Blaney, Peter B. Jahrling	12
12	The lipid moiety of brincidofovir is required for in vitro antiviral activity against Ebola virus 2015 ·Antiviral Research ·Laura K. McMullan, Mike Flint, Julie Dyall, César G. Albariño, Gene G. Olinger, Scott A. Foster, Phiroze Sethna, Lisa E. Hensley, Stuart T. Nichol, E. Randall Lanier, Christina F. Spiropoulou	36
13	Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis breakdown → 2014 ·Antimicrobial Agents and Chemotherapy ·Jason Kindrachuk, (unknown), Brit J. Hart, Steven Mazur, Michael R. Holbrook, Matthew B. Frieman, (unknown), Reed F. Johnson, Julie Dyall, Jens H. Kuhn, Gene G. Olinger, Lisa E. Hensley, Peter B. Jahrling	307
14	The effect of volume of interest definition on quantification of lymph node immune response to a monkeypox virus infection assessed by 18F-FDG-PET 2014 ·EJNMMI Research ·Svetlana I. Chefer, Richard C. Reba, (unknown), Jürgen Seidel, Reed F. Johnson, Joseph E. Blaney, Peter B. Jahrling, Julie Dyall	2
15	Poxvirus Antigen Staining of Immune Cells as a Biomarker to Predict Disease Outcome in Monkeypox and Cowpox Virus Infection in Non-Human Primates 2013 ·PLoS ONE ·Haifeng Song, Krisztina Janosko, Reed F. Johnson, Jing Qin, Nicole Josleyn, Catherine Jett, Russell Byrum, Marisa St. Claire, Julie Dyall, Joseph E. Blaney, Gerald B. Jennings, Peter B. Jahrling	28
16	Optimization of automated segmentation of monkeypox virus-induced lung lesions from normal lung CT images using hard C-means algorithm 2013 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Marcelo A. Castro, David Thomasson, Nilo A. Avila, (unknown), (unknown), Reed F. Johnson, Julie Dyall	1
17	Inhibition of cowpox virus and monkeypox virus infection by mitoxantrone 2011 ·Antiviral Research ·(unknown), Alvin L. Smith, Julie Dyall, Reed F. Johnson, Lori E. Dodd, Peter B. Jahrling, Jason Paragas, Joseph E. Blaney	19
18	Evaluation of Monkeypox Disease Progression by Molecular Imaging 2011 ·The Journal of Infectious Diseases ·Julie Dyall, Reed F. Johnson, (unknown), Louis Huzella, Dan R. Ragland, Daniel J. Mollura, Russell Byrum, Richard C. Reba, Gerald B. Jennings, Peter B. Jahrling, Joseph E. Blaney, Jason Paragas	33
19	Comparative Analysis of Monkeypox Virus Infection of Cynomolgus Macaques by the Intravenous or Intrabronchial Inoculation Route 2010 ·Journal of Virology ·Reed F. Johnson, Julie Dyall, Dan R. Ragland, Louis Huzella, Russell Byrum, Catherine Jett, Marisa St. Claire, Alvin L. Smith, Jason Paragas, Joseph E. Blaney, Peter B. Jahrling	69
20	Virus-inducible reporter genes as a tool for detecting and quantifying influenza A virus replication 2005 ·Journal of Virological Methods ·(unknown), Julie Dyall, Paul D. Olivo, Andrew Pekosz	86

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact